Aktis Oncology, Inc. (AKTS)
18.99
+0.02
(+0.11%)
USD |
NASDAQ |
Jun 09, 16:00
18.99
0.00 (0.00%)
After-Hours: 20:00
Aktis Oncology EPS Diluted (Quarterly) : -0.3315 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MetaVia, Inc. | -0.7867 |
| ACADIA Pharmaceuticals, Inc. | 0.0211 |
| Alnylam Pharmaceuticals, Inc. | 1.508 |
| Savara, Inc. | -0.1472 |
| Vericel Corp. | -0.1241 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -18.32M |
| Revenue (Quarterly) | 3.227M |
| Total Expenses (Quarterly) | 21.55M |
| Enterprise Value | 521.68M |
| Gross Profit Margin (Quarterly) | 79.80% |
| Profit Margin (Quarterly) | -567.9% |
| Earnings Yield | -5.92% |
| Normalized Earnings Yield | -5.925 |